Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era
Author(s) -
Bernhard Resch,
Beatrice Egger,
Stefan KurathKoller,
Berndt Urlesberger
Publication year - 2017
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2017.01.034
Subject(s) - palivizumab , medicine , gestational age , pediatrics , respiratory system , cohort , population , respiratory tract infections , pregnancy , environmental health , biology , genetics
To obtain data on respiratory syncytial virus (RSV) associated hospitalization rates in preterm infants of 28 weeks gestational age and less in the era of palivizumab prophylaxis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom